Target
Interleukin-1 receptor-associated kinase 4
Ligand
BDBM50239500
Substrate
n/a
Meas. Tech.
IRAK4 Enzymatic DELFIA Assay, Protocol A
IC50
0.100±n/a nM
Citation
 Trzupek, JDLee, KLBunnage, MEHan, SHepworth, DLovering, FEMathias, JPPapaioannou, NPierce, BSStrohbach, JWWright, SWZapf, CWGavrin, LKLee, AAnderson, DRCurran, KJDehnhardt, CMSaiah, EGoldberg, JAWang, XHuang, HVargas, RLowe, MDPatny, A Bicyclic-fused heteroaryl or aryl compounds US Patent  US10329302 Publication Date 6/25/2019 
Target
Name:
Interleukin-1 receptor-associated kinase 4
Synonyms:
IRAK-4 | IRAK4 | IRAK4_HUMAN | Interleukin-1 receptor-associated kinase 4 (IRAK-4) | Interleukin-1 receptor-associated kinase 4 (IRAK4) | Renal carcinoma antigen NY-REN-64
Type:
Protein
Mol. Mass.:
51519.08
Organism:
Homo sapiens (Human)
Description:
Q9NWZ3
Residue:
460
Sequence:
MNKPITPSTYVRCLNVGLIRKLSDFIDPQEGWKKLAVAIKKPSGDDRYNQFHIRRFEALLQTGKSPTSELLFDWGTTNCTVGDLVDLLIQNEFFAPASLLLPDAVPKTANTLPSKEAITVQQKQMPFCDKDRTLMTPVQNLEQSYMPPDSSSPENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS
  
Inhibitor
Name:
BDBM50239500
Synonyms:
CHEMBL4066705 | US10329302, Example 337 | US10793579, Example 337 | US11702424, Example 337
Type:
Small organic molecule
Emp. Form.:
C18H20FN3O4
Mol. Mass.:
361.3675
SMILES:
CC[C@H]1[C@@H](COc2nccc3cc(C(N)=O)c(OC)cc23)NC(=O)[C@@H]1F |r|
Structure:
Search PDB for entries with ligand similarity: